These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 22513366

  • 1. Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.
    Martens HA, Nienhuis HL, Gross S, van der Steege G, Brouwer E, Berden JH, de Sévaux RG, Derksen RH, Voskuyl AE, Berger SP, Navis GJ, Nolte IM, Kallenberg CG, Bijl M.
    Lupus; 2012 Aug; 21(9):959-68. PubMed ID: 22513366
    [Abstract] [Full Text] [Related]

  • 2. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH.
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [Abstract] [Full Text] [Related]

  • 3. Fcgamma receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.
    Lee YH, Ji JD, Song GG.
    Lupus; 2009 Jul; 18(8):727-34. PubMed ID: 19502269
    [Abstract] [Full Text] [Related]

  • 4. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis.
    Tucci M, Barnes EV, Sobel ES, Croker BP, Segal MS, Reeves WH, Richards HB.
    Arthritis Rheum; 2004 Jun; 50(6):1842-9. PubMed ID: 15188361
    [Abstract] [Full Text] [Related]

  • 5. The plasma level of soluble receptor for advanced glycation end products is decreased in patients with systemic lupus erythematosus.
    Ma CY, Ma JL, Jiao YL, Li JF, Wang LC, Yang QR, You L, Cui B, Chen ZJ, Zhao YR.
    Scand J Immunol; 2012 Jun; 75(6):614-22. PubMed ID: 22324318
    [Abstract] [Full Text] [Related]

  • 6. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
    Däbritz J, Friedrichs F, Weinhage T, Hampe J, Kucharzik T, Lügering A, Broeckel U, Schreiber S, Spieker T, Stoll M, Foell D.
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
    [Abstract] [Full Text] [Related]

  • 7. Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes.
    Jönsen A, Gunnarsson I, Gullstrand B, Svenungsson E, Bengtsson AA, Nived O, Lundberg IE, Truedsson L, Sturfelt G.
    Rheumatology (Oxford); 2007 Sep; 46(9):1417-21. PubMed ID: 17596285
    [Abstract] [Full Text] [Related]

  • 8. p21 gene polymorphisms in systemic lupus erythematosus.
    Kong EK, Chong WP, Wong WH, Lau CS, Chan TM, Ng PK, Song YQ, Mak W, Lau YL.
    Rheumatology (Oxford); 2007 Feb; 46(2):220-6. PubMed ID: 16837471
    [Abstract] [Full Text] [Related]

  • 9. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis.
    Malafronte P, Vieira JM, Pereira AC, Krieger JE, Barros RT, Woronik V.
    J Rheumatol; 2010 Apr; 37(4):776-82. PubMed ID: 20231199
    [Abstract] [Full Text] [Related]

  • 10. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
    Krechler T, Jáchymová M, Mestek O, Zák A, Zima T, Kalousová M.
    Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
    [Abstract] [Full Text] [Related]

  • 11. Independent association of HLA-DR and FCgamma receptor polymorphisms in Korean patients with systemic lupus erythematosus.
    Lee HS, Chung YH, Kim TG, Kim TH, Jun JB, Jung S, Bae SC, Yoo DH.
    Rheumatology (Oxford); 2003 Dec; 42(12):1501-7. PubMed ID: 12867584
    [Abstract] [Full Text] [Related]

  • 12. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
    Sayed SK, Galal SH, Herdan OM, Mahran AM.
    Egypt J Immunol; 2014 Dec; 21(2):9-21. PubMed ID: 25812349
    [Abstract] [Full Text] [Related]

  • 13. The association of single nucleotide polymorphism within vascular endothelial growth factor gene with systemic lupus erythematosus and lupus nephritis.
    Wongpiyabovorn J, Hirankarn N, Ruchusatsawat K, Yooyongsatit S, Benjachat T, Avihingsanon Y.
    Int J Immunogenet; 2011 Feb; 38(1):63-7. PubMed ID: 20670331
    [Abstract] [Full Text] [Related]

  • 14. Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.
    Dijstelbloem HM, Bijl M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD, Sluiter WJ, Limburg PC, Derksen RH, van de Winkel JG, Kallenberg CG.
    Arthritis Rheum; 2000 Dec; 43(12):2793-800. PubMed ID: 11145038
    [Abstract] [Full Text] [Related]

  • 15. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
    Gaens KH, Ferreira I, van der Kallen CJ, van Greevenbroek MM, Blaak EE, Feskens EJ, Dekker JM, Nijpels G, Heine RJ, 't Hart LM, de Groot PG, Stehouwer CD, Schalkwijk CG.
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
    [Abstract] [Full Text] [Related]

  • 16. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
    Tesarová P, Kalousová M, Jáchymová M, Mestek O, Petruzelka L, Zima T.
    Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
    [Abstract] [Full Text] [Related]

  • 17. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
    Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, Fukazawa T, Jansen MD, Hashimoto H, van de Winkel JG, Kallenberg CG, Tokunaga K.
    Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
    [Abstract] [Full Text] [Related]

  • 18. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA, Zuurman MW, de Lange AH, Nolte IM, van der Steege G, Navis GJ, Kallenberg CG, Seelen MA, Bijl M.
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus.
    Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G.
    J Rheumatol; 2004 Sep; 31(9):1756-62. PubMed ID: 15338496
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus.
    Sánchez E, Morales S, Paco L, López-Nevot MA, Hidalgo C, Jiménez-Alonso J, Torres B, González-Gay MA, Callejas JL, Ortego-Centeno N, Sánchez-Roman J, González-Escribano MF, Martín J.
    Rheumatology (Oxford); 2005 Sep; 44(9):1136-9. PubMed ID: 15941730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.